CVI-VZV-001 for chickenpox

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 19 Mar 2026: Trial registered, NCT07481604
  2. 17 Apr 2026: Trial started, NCT07481604

The trials

NCT07481604: Safety and Immunogenicity of CVI-VZV-001 in Adults Aged 50 Years and Above

State
Under way
Phase
Phase 2
People
135 planned
Started
17 Apr 2026
Primary completion
Jan 2027
Arms
CVI-VZV-001 Low Dose, CVI-VZV-001 High Dose
Results
None posted
  1. 19 Mar 2026: Trial registered
  2. 17 Apr 2026: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.